Ginkgo Bioworks Holdings, Inc. (DNA) insider buying and selling

NYSE: DNA · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at Ginkgo Bioworks Holdings, Inc. (DNA), no insider made an open-market purchase and 1 insider made 1 open-market sale worth $2K, as reported on SEC Form 4. The sale was scheduled in advance or made to cover tax on vesting shares, so they say less about the insider's view of the stock. Over the last 12 months, 1 insider sold $11K, of which $11K was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
1
$2K · 1 insider
Insider buys, 12 months
0
$0 · 0 insiders
Insider sales, 12 months
3
$11K · 1 insider

This is the public summary. Create a free account to see DNA’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock DNA

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

No discretionary open-market insider trades were reported in the last 12 months.

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at Ginkgo Bioworks Holdings, Inc.
DateInsiderTypeSharesPriceValue
Steven P. Coen
See remarks
Sell to cover330$6.98$2K
Steven P. Coen
See remarks
Sell to cover752$7.90$6K
Steven P. Coen
See remarks
Sell to cover307$8.33$3K

What the DNA insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for Ginkgo Bioworks Holdings, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with DNA Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about DNA insider trading

Who bought Ginkgo Bioworks Holdings, Inc. (DNA) stock recently?

No insider made an open-market purchase of Ginkgo Bioworks Holdings, Inc. (DNA) stock in the last 12 months.

Are insiders buying or selling DNA?

Insiders made no discretionary trades in DNA over the last 12 months; the only sales were scheduled or tax-related.

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see DNA in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.